martes, 1 de marzo de 2022

Recombinant adenovirus vector vaccine generates mucosal antibodies against SARS-CoV-2

Recombinant adenovirus vector vaccine generates mucosal antibodies against SARS-CoV-2

No hay comentarios:

Publicar un comentario